ATE330010T1 - Denaturierter low-density lipoprotein (ldl) rezeptor - Google Patents

Denaturierter low-density lipoprotein (ldl) rezeptor

Info

Publication number
ATE330010T1
ATE330010T1 AT95938615T AT95938615T ATE330010T1 AT E330010 T1 ATE330010 T1 AT E330010T1 AT 95938615 T AT95938615 T AT 95938615T AT 95938615 T AT95938615 T AT 95938615T AT E330010 T1 ATE330010 T1 AT E330010T1
Authority
AT
Austria
Prior art keywords
density lipoprotein
receptor
ldl
denatured low
sequence
Prior art date
Application number
AT95938615T
Other languages
English (en)
Inventor
Tatsuya Sawamura
Tomoo Masaki
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Application granted granted Critical
Publication of ATE330010T1 publication Critical patent/ATE330010T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT95938615T 1994-11-30 1995-11-30 Denaturierter low-density lipoprotein (ldl) rezeptor ATE330010T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP32170594 1994-11-30
JP21420695 1995-07-31

Publications (1)

Publication Number Publication Date
ATE330010T1 true ATE330010T1 (de) 2006-07-15

Family

ID=26520189

Family Applications (2)

Application Number Title Priority Date Filing Date
AT95938615T ATE330010T1 (de) 1994-11-30 1995-11-30 Denaturierter low-density lipoprotein (ldl) rezeptor
AT06012158T ATE483808T1 (de) 1994-11-30 1995-11-30 Rezeptor für modifizierte lipoprotein niedriges molekulargewichtes

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT06012158T ATE483808T1 (de) 1994-11-30 1995-11-30 Rezeptor für modifizierte lipoprotein niedriges molekulargewichtes

Country Status (11)

Country Link
US (2) US5962260A (de)
EP (2) EP0795605B1 (de)
JP (4) JP3919839B2 (de)
AT (2) ATE330010T1 (de)
AU (2) AU693289B2 (de)
CA (1) CA2200980C (de)
DE (2) DE69536113D1 (de)
DK (1) DK0795605T3 (de)
ES (1) ES2265149T3 (de)
PT (1) PT795605E (de)
WO (1) WO1996017058A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0795605T3 (da) * 1994-11-30 2006-10-09 Nippon Chemiphar Co Denatureret lavdensitetslipoprotein-receptor
CA2252088A1 (en) * 1996-04-19 1997-10-30 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US5792648A (en) * 1996-07-31 1998-08-11 Incyte Pharmaceuticals, Inc. Human macrophage antigen
JP2002017353A (ja) * 1997-12-19 2002-01-22 Japan Tobacco Inc 変性ｌｄｌの定量方法
US5945308A (en) * 1998-04-03 1999-08-31 Incyte Pharmaceuticals, Inc. Human oxidized LDL receptor
JP4497586B2 (ja) * 1998-08-06 2010-07-07 達也 沢村 酸化ｌｄｌ受容体に対する抗体を含んでなる医薬組成物
JP5232818B2 (ja) * 1998-08-06 2013-07-10 達也 沢村 酸化ｌｄｌ受容体に対する抗体を含んでなる医薬組成物
US7013021B2 (en) * 1999-03-19 2006-03-14 Digimarc Corporation Watermark detection utilizing regions with higher probability of success
AU5446700A (en) * 1999-05-28 2000-12-18 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector
CA2401993A1 (en) * 2000-03-02 2001-09-07 Abgenix, Inc. Human monoclonal antibodies against oxidized ldl receptor and pharmaceutical uses thereof
AU2006203702B2 (en) * 2000-03-02 2009-07-16 Abgenix, Inc. Human monoclonal antibodies against oxidized LDL receptor and medicinal use thereof
US6756228B2 (en) 2001-07-02 2004-06-29 The Trustees Of Columbia University In The City Of New York Atherosclerosis susceptibility gene locus 1 (Athsq1) and atherosclerosis susceptibility gene locus 2 (Athsq2)
US20050089471A1 (en) * 2003-10-24 2005-04-28 Johnson Bruce F. Labeled ligands for lectin-like oxidized low-density lipoprotein receptor (LOX-1)
US7897749B2 (en) * 2005-07-13 2011-03-01 Wisconsin Alumni Research Foundation Dairy cattle breeding for improved milk production traits in cattle
TW200819465A (en) 2006-07-28 2008-05-01 Shionogi & Co Monoclonal antibody for soluble LOX-1
JP5706669B2 (ja) * 2010-11-10 2015-04-22 独立行政法人国立循環器病研究センター 融合タンパク質、核酸、ベクター、細胞、ｌａｂの測定方法、並びに、ｌａｂ測定用キット
WO2013190679A1 (ja) * 2012-06-21 2013-12-27 独立行政法人国立循環器病研究センター 融合タンパク質、核酸、ベクター、細胞、ｌａｂの測定方法、並びに、ｌａｂ測定用キット
UY35620A (es) 2013-06-21 2015-01-30 Novartis Ag Anticuerpos del receptor 1 de ldl oxidado similar a lectina y métodos de uso
AR096601A1 (es) 2013-06-21 2016-01-20 Novartis Ag Anticuerpos del receptor 1 de ldl oxidado similar a lectina y métodos de uso
WO2021177333A1 (ja) 2020-03-03 2021-09-10 国立大学法人信州大学 アディポネクチンの定量方法及びそれに用いる分析用試薬
CN115698713A (zh) 2020-03-30 2023-02-03 国立大学法人信州大学 改性hdl的定量方法以及用于该定量方法的分析用试剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208144A (en) * 1988-08-23 1993-05-04 The General Hospital Corporation Method for detection of human dna containing the gene encoding low density lipoprotein receptor
CA1340977C (en) * 1988-11-15 2000-04-25 Monty Krieger Scavenger receptor protein and antibody thereto
JPH03290184A (ja) * 1990-04-06 1991-12-19 Chugai Pharmaceut Co Ltd スカベンジャーレセプター産生動物細胞
US5380747A (en) * 1992-10-30 1995-01-10 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
DK0795605T3 (da) * 1994-11-30 2006-10-09 Nippon Chemiphar Co Denatureret lavdensitetslipoprotein-receptor
JPH09163988A (ja) * 1995-10-09 1997-06-24 Kowa Co 新規なｌｄｌ受容体類似蛋白質及び遺伝子

Also Published As

Publication number Publication date
EP0795605A4 (de) 1999-11-03
JP4203097B2 (ja) 2008-12-24
ATE483808T1 (de) 2010-10-15
JP2008263992A (ja) 2008-11-06
JP2007175053A (ja) 2007-07-12
EP0795605B1 (de) 2006-06-14
WO1996017058A1 (en) 1996-06-06
AU3993995A (en) 1996-06-19
CA2200980A1 (en) 1996-06-06
AU710373B2 (en) 1999-09-16
AU8711098A (en) 1998-11-12
EP1717314A1 (de) 2006-11-02
EP0795605A1 (de) 1997-09-17
CA2200980C (en) 2009-09-22
US6197937B1 (en) 2001-03-06
DE69535063D1 (de) 2006-07-27
JP3919839B2 (ja) 2007-05-30
AU693289B2 (en) 1998-06-25
JP4203077B2 (ja) 2008-12-24
DE69536113D1 (de) 2010-11-18
EP1717314B1 (de) 2010-10-06
DK0795605T3 (da) 2006-10-09
DE69535063T2 (de) 2006-12-21
JPH0998787A (ja) 1997-04-15
US5962260A (en) 1999-10-05
PT795605E (pt) 2006-10-31
ES2265149T3 (es) 2007-02-01
JP2006271386A (ja) 2006-10-12

Similar Documents

Publication Publication Date Title
ATE330010T1 (de) Denaturierter low-density lipoprotein (ldl) rezeptor
DE69635524D1 (de) Antiparasitäre marcfortine und paraherquamide
CY1110549T1 (el) Ικριωματα πρωτεϊνων για μιμητικα αντισωματων και αλλες πρωτεϊνες συνδεσης
BG102622A (en) Halogenopyramidines and their application as pest control forms
ID21924A (id) Olanzapin dihidrat d
DE60141546D1 (de) Polypeptide enthaltend extrazellulären Domäne von IL-20RA und/oderr IL-20RB
ATE213005T1 (de) Kontinuierliches polymerisationverfahren von polyamiden
ATE225665T1 (de) Universell verwendbares bluttplasma
NO924847D0 (no) Dna-molekyler og verter
EP1155700A3 (de) Chemoattraktion-auslösender Faktor aus Lymfozyten und dessen Verwendungen
CA2259672A1 (fr) Element de liaison et de couverture de joint et main courante ou analogue comportant au moins un tel element
ATE180875T1 (de) Montagehilfsvorrichtung zur sicherung von bauteilen
ES2073495T3 (es) Benzotiazepinas.
SE9302856D0 (sv) Method and means for producing a plasmapeotein-binding protein
SE9403591L (sv) Anordning för att befrämja barns identitetsutveckling
ITPS950021V0 (it) Sega taglia-muri scomponibile in due parti a mezzo di un particolare innesto che consente un'agevole messa in opera della macchina e vincola le parti nella posizione prestabilita sul piano orizzontale e verticale
IT231719Y1 (it) Pianale per l'appoggio di materiale tessile semilavorato o simile.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0795605

Country of ref document: EP